Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 9,500 | |||
25 mg | 在庫あり | ¥ 18,500 | |||
50 mg | 在庫あり | ¥ 30,000 | |||
100 mg | 在庫あり | ¥ 45,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,000 |
説明 | ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6. |
ターゲット&IC50 | HCV NS5A:1.4-5.0 pM(EC50) |
別名 | ABT 530, ABT-530, Pibrentasvir |
分子量 | 1113.18 |
分子式 | C57H65F5N10O8 |
CAS No. | 1353900-92-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (44.92 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABT530 1353900-92-1 Microbiology/Virology Proteases/Proteasome HCV Protease ABT 530 ABT-530 Pibrentasvir Inhibitor inhibitor inhibit